Postpartum Preeclampsia
20
2
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.0%
1 terminated out of 20 trials
91.7%
+5.2% vs benchmark
40%
8 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (20)
Postpartum Hypertension Study
Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study
Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy
Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring Guidelines
Postpartum Video Education in High Risk Populations
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
Lasix for the Prevention of De Novo Postpartum Hypertension
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Management of Postpartum Preeclampsia
Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Postpartum Video Education
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
Assessment of Postpartum Education to Improve Compliance
Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients With Severe Preeclampsia
Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension